CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

ACHIEVE LIFE SCIENCES, INC.

ACHV
$498M
Small Cap
NASDAQIn Vitro & In Vivo Diagnostic Substances🇺🇸North AmericaSEATTLE

Drugs in Pipeline

11

Phase 3 Programs

5

Upcoming Catalysts

1

Next Catalyst

Aug 6, 2026

4w

Market Overview

Stock performance and key metrics

ACHV News
Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in ACHIEVE LIFE SCIENCES, INC.'s drug pipeline?

CatalystAlert tracks 11 drug candidates in ACHIEVE LIFE SCIENCES, INC.'s (ACHV) pipeline across Phase 3, Phase 2. Its lead program is Docetaxel (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is ACHIEVE LIFE SCIENCES, INC.'s next FDA catalyst?

ACHIEVE LIFE SCIENCES, INC.'s (ACHV) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ACHV biotech catalysts?

Add ACHV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ACHIEVE LIFE SCIENCES, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply